2 results
Not approvedWill not start
To compare the EPOS guideline with the free choice treatment of the GP for acute rhinosinusitis in general practice.
Approved WMORecruiting
Primary objective: To evaluate the effect of navitoclax in combination with ruxolitinib on splenomegaly response when compared to ruxolitinib in subjects with myelofibrosis.Secondary objectives:• To evaluate the effect of navitoclax in combination…